Hi-Tech Pharmacal Co. (HITK) Misses Q4 EPS by 8c; Revs Light
Tweet Send to a FriendGet Alerts HITK Hot Sheet
Price: $32.27 +2.64%
Financial Fact:
Research and product development costs: 5.96M
Today's EPS Names:
LBIX, ESEA, ISS, More
Financial Fact:
Research and product development costs: 5.96M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade HITK Now!
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q4 EPS of $0.79, $0.08 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $55.63 million versus the consensus estimate of $55.73 million.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- iSoftStone Holdings (ISS) Tops Q1 EPS by 1c; Guides Q2, FY13
- Hollsys (HOLI) Tops Q3 EPS by 1c; Lowers FY13 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
